Castle Biosciences, Inc. (CSTL)

Castle Biosciences Revenue

Castle Biosciences had revenue of $86.19M in the quarter ending June 30, 2025, a decrease of -0.94%. This brings the company's revenue in the last twelve months to $346.27M, up 20.40% year-over-year. In the year 2024, Castle Biosciences had annual revenue of $332.07M with 51.09% growth.

• Revenue (ttm): $346.27M
• Revenue Growth: +20.40%
• P/S Ratio: 1.59
• Revenue / Employee: $455,018
• Employees: 761
• Market Cap: 563.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	332.07M	112.28M	51.09%
Dec 31, 2023	219.79M	82.75M	60.38%
Dec 31, 2022	137.04M	42.95M	45.65%
Dec 31, 2021	94.09M	31.44M	50.18%
Dec 31, 2020	62.65M	10.78M	20.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.